QA: Viracta Therapeutics Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001061027_2018_Viracta_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001061027, Viracta Therapeutics Inc

  xvar xval
0 AssetsCurrent 32,933,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 20,000
3 remainder_Assets 1,381,000
4 LiabilitiesCurrent 12,678,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,624,333
9 ResearchAndDevelopmentExpense 21,031,981
10 remainder_Expenses 1,357,335
11 remainder_Revenues 1,006,613
12 remainder_NetIncome 287,129
13 remainder_ComprehensiveNetIncome 8,761
  yvar yval
0 Assets 34,334,000
1 Liabilities 12,678,000
2 Expenses 36,013,649
3 Revenues 1,006,613
4 StockholdersEquity 21,656,000
5 NetIncome -34,719,907
6 ComprehensiveNetIncome -34,715,526
7 BaseVar 42,164,076
8 EconomicCapitalRatiobeforeLimitedLiability 0.532
9 EconomicCapitalRatio 1.91

Edgar->Model Mapping

Feature Distribution

Change over Time